Back to search

Article

Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patients

2023-03-31

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is a malignancy with a high global incidence and cancer-related mortality rate. Although various clinical trials have improved the prognosis of LUAD patients, the 5-year survival rate is still low. This study aimed to improve the prognosis of LUAD patients through molecular subtype-based precision therapy. Methods LUAD RNA sequencing (RNA-seq) data obtained from on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24bb3483-ecb1-5313-9fd9-36ac13d13fef
DOI
10.21203/rs.3.rs-2713906/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsDOI 10.21203/rs.3.rs-2713906/v1
Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsSemantic proximity
Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional charactersSemantic proximity
Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.Semantic proximity
Genomic Features and Prognostic Biomarkers of Chinese Resectable Lung Adenocarcinoma Patients with a Micropapillary ComponentSemantic proximity
Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise MedicineSemantic proximity
Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity
Lactate gene signature based on mitophagy predict the prognosis and immune response in lung adenocarcinomaSemantic proximity
Identification of Molecular Subtypes and a Prognostic Signature Based on m6A/m5C/m1A-Related Genes in Lung adenocarcinomaSemantic proximity
Comprehensive Analysis of KPNA2 as a Prognostic Biomarker in Lung Adenocarcinoma: Associations with Ferroptosis and Immune InfiltrationSemantic proximity
Identification of lung adenocarcinoma subtypes and a prognostic signature based on activity changes of the hallmark and immunologic gene setsSemantic proximity
Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine LearningSemantic proximity
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung AdenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.